Trial
NCT05301894
Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Neurocrine Biosciences
Collaborators
—
Condition
Epileptic Encephalopathy
Intervention
NBI-827104
Why stopped
Business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-13